MAIA Biotechnology Inc.

MAIA | AMEX

Price Alert Chart Builder DCF Calculator

$1.34

+$0.01 (+0.75%)

Sep 22, 2026, 12:48 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.75%

(1D)

Rating

Updated: Sep 18, 2026

31.8

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $81.47M

1D Range

1.31 1.34

52W Range

0.87 3.19

Valuation (TTM)

PE -2.11

PB 3.91

EV/EBITDA -3.11

Valuation (NTM)

Forward PE 2.22

Forward PEG 0.19

Price Target N/A

Cash Flow

FCF Yield -27.9%

SBC Adj. FCF Yield -31.4%

SBC Impact -12.6%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 51.3% | 22.7%

FCF 3Y | 5Y -19.9% | -22.0%

Returns

ROA -95.1%

ROE -211.2%

ROIC -131.7%

Financial Health

Net Cash

$27.6M

Current Ratio 4.51

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. ...

Sector Healthcare

Industry Biotechnology

Employees 13

IPO Date Jul 27, 2022

Website www.MAIABiotech.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.